This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
10 October 2022
In the version of this article initially published, discussion in the fifth paragraph referring to “bispecific antibodies” originally used the term “BiTEs”; the text has been updated in the HTML and PDF versions of the article.
References
Anonymous. BioSpace https://www.biospace.com/article/investment-in-biopharma-is-reaching-an-inflection-point-/ (2021).
Snyder, A. et al. Preprint at medRxiv https://doi.org/10.1101/2022.06.03.22275971 (2022).
Sachs, J. R. et al. Clin. Cancer Res. 22, 1318–1324 (2016).
Villela, L. R. et al. Pharmacotherapy 26, 641–654 (2006).
Jabbour, E. et al. Nat. Rev. Clin. Oncol. 18, 418–433 (2021).
Abramson, J. S. et al. Lancet 396, 839–852 (2020).
Adans, B. Fierce Biotech https://www.fiercebiotech.com/biotech/regeneron-s-blood-cancer-hopeful-odronextamab-hit-fda-partial-hold-across-several-trials (2020).
Hosseini, I. et al. NPJ Syst. Biol. Appl. 6, 28 (2020).
Goonewardene, A. et al. Truist Securities Research (June 2022); available upon request to authors.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
A.S. is an employee of Generate Biomedicines and owns shares in Allogene and Merck. P.S.H. is an employee of Foundation Medicine, Inc. and owns shares in Roche, Bolt Therapeutics and TCR2. D.D. is an employee of and owns shares in Merck, Inc.
Rights and permissions
About this article
Cite this article
Snyder, A., De Alwis, D., Goonewardene, A. et al. Balancing speed, science and regulatory requirements in oncology drug development. Nat Med 28, 2234–2235 (2022). https://doi.org/10.1038/s41591-022-01975-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-01975-0